Compounded medications can offer a cheaper way to obtain scarce drugs. But the FDA has raised concerns about salt-compounded forms of semaglutide, which may not be safe or effective. Share on ...

Most compounded versions of popular drugs used for weight loss including Wegovy and Zepbound may soon no longer be available after a U.S. judge declined an initial injunction to allow compounding ...

The US Food and Drug Administration issued a warning Tuesday about compounded versions of the drug semaglutide, which is approved for treatment of diabetes and excess weight. Compounding “is the ...

Compounded tirzepatide contains the same active ingredient as Mounjaro, but its dosage and some ingredients may differ from Mounjaro. The Food and Drug Administration (FDA) does not regulate the ...

Novo Nordisk recently made headlines petitioning FDA to stop the compounding of its blockbuster GLP-1 products so it can sell its patented semaglutide drugs exclusively. Compounding is the practice of ...

Incentivizing innovation requires the protection of intellectual property rights. Allowing compounded pharmacies to sell unauthorized versions undermines these rights.

Compounding pharmacies are facilities that are able to make customized medications. This could be to alter a drug's dosage or composition for medical purposes. Many patients have benefitted from drug ...

Unlike conventional pharmacies, which mostly dispense premade drugs in standard doses, compounding pharmacies make, or "compound," medications on the premises, according to federal guidelines. For ...

Joanne Whitney, PharmD, PhD, director of the Drug Product Services Lab (DPSL), will explain why clinical researchers need an academic compounding facility today (Jan. 17). Whitney will talk about the ...

The United States Food and Drug Administration (FDA) has stopped the sale of copycat versions of Ozempic and Wegovy, the Type 2 diabetes drugs used for weight loss. In 2022, the FDA announced there ...

In an effort to prevent disease outbreaks similar to the cases of meningitis caused by the New England Compounding Center in October 2012, the Massachusetts House of Representatives unanimously voted ...